Celgene Corporation Contingent Value Rights
CELGZ
CELGZ was delisted on the 29th of November, 2019.
20 hedge funds and large institutions have $344K invested in Celgene Corporation Contingent Value Rights in 2019 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 20 → 20 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
47% less capital invested
Capital invested by funds: $654K → $344K (-$310K)
50% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$7.34K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$339 |
| 3 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$65 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CC
Cannell & Co
New York
|
-$40.7K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$6.85K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$1.53K |
| 4 |
Koshinski Asset Management
Decatur,
Illinois
|
-$1.44K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
DC
1
Davenport & Co
Richmond,
Virginia
| $71K | – | – | – |
|
|
FA
2
FCG Advisors
Chatham,
New Jersey
| $68K | – | – | – |
|
|
CC
3
Cannell & Co
New York
| $62K | -$40.7K | -56,718 | -36% |
|
|
4
Citadel Advisors
Miami,
Florida
| $53K | +$7.34K | +10,221 | +14% |
|
|
5
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $47K | +$339 | +472 | +0.6% |
|
6
California Public Employees Retirement System
Sacramento,
California
| $11K | – | – | – |
|
|
7
Koshinski Asset Management
Decatur,
Illinois
| $10K | -$1.44K | -2,000 | -11% |
|
|
BFA
8
Beaumont Financial Advisors
Needham,
Massachusetts
| $9K | – | – | – |
|
|
DAM
9
Deltec Asset Management
New York
| $7K | – | – | – |
|
10
First Manhattan
New York
| $3K | – | – | – |
|
|
11
Bank of America
Charlotte,
North Carolina
| $1K | -$1.53K | -2,127 | -55% |
|
|
BWM
12
Baystate Wealth Management
Boston,
Massachusetts
| $1K | – | – | – |
|
13
Morgan Stanley
New York
| $1K | – | – | – |
|
|
14
UBS Group
Zurich,
Switzerland
| – | -$6.85K | -9,543 | -100% |
|
|
15
Bank of Montreal
Toronto,
Ontario, Canada
| – | +$65 | +90 | New |
|
CELGZ Hedge Fund Activity: Q2 2019 in Review
20 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Celgene Corporation Contingent Value Rights (CELGZ) for Q2 2019, worth a combined $344K — down 47% from $654K a quarter earlier.
Fund positioning in CELGZ was balanced in Q2 2019: 1 fund opened new positions, 1 closed out, 2 added to existing stakes and 4 trimmed.
The largest buyer was Citadel Advisors, adding an estimated $7.34K. The largest seller was Cannell & Co, cutting an estimated $40.7K.
- 20 institutional investors held Celgene Corporation Contingent Value Rights (CELGZ) as of Q2 2019, unchanged from Q1 2019.
- Funds reported $344K of Celgene Corporation Contingent Value Rights stock for Q2 2019, down 47% quarter-over-quarter.
- 1 fund opened new Celgene Corporation Contingent Value Rights positions in Q2 2019 and 1 closed out, a net change of 0 holders.
- The largest Celgene Corporation Contingent Value Rights buyer in Q2 2019 was Citadel Advisors, an estimated $7.34K added.
- The largest Celgene Corporation Contingent Value Rights seller in Q2 2019 was Cannell & Co, an estimated $40.7K sold.
Based on aggregated 13F filings for Q2 2019.